secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
CIK:        0001137883
Form:       8-K
Filed at:   2026-02-27T23:59:59+00:00
Accession:  0001104659-26-021613
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Brainstorm Cell Therapeutics raises $1M in private placement, increases share pool by 5.5M
--------------------------------------------------------------------------------

- Entered securities purchase agreement for $1M private placement; initial closing of $125K at $0.60/share.
- Investor may purchase up to $875K in additional closings through Sept 25, 2026, with common warrants at $1.00/share.
- Board approved 5.5M share increase in 2014 stock incentive plan pool, now totaling ~8.4M shares.
- Proceeds from private placement to be used for working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1137883/000110465926021613/0001104659-26-021613-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1137883/000110465926021613/tm267482d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-021613

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer